[go: up one dir, main page]

FI811542L - PAO MAGNESIUM ALUMINUM HYDROXIDE BASERAT SYRA NEUTRALISERANDE AEMNE OCH DESS FRAMSTAELLNING - Google Patents

PAO MAGNESIUM ALUMINUM HYDROXIDE BASERAT SYRA NEUTRALISERANDE AEMNE OCH DESS FRAMSTAELLNING

Info

Publication number
FI811542L
FI811542L FI811542A FI811542A FI811542L FI 811542 L FI811542 L FI 811542L FI 811542 A FI811542 A FI 811542A FI 811542 A FI811542 A FI 811542A FI 811542 L FI811542 L FI 811542L
Authority
FI
Finland
Prior art keywords
neutraliserande
baserat
syra
pao
magnesium
Prior art date
Application number
FI811542A
Other languages
Finnish (fi)
Other versions
FI72652C (en
FI72652B (en
Inventor
Adolf Knecht
Michael Schneider
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of FI811542L publication Critical patent/FI811542L/en
Application granted granted Critical
Publication of FI72652B publication Critical patent/FI72652B/en
Publication of FI72652C publication Critical patent/FI72652C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F7/00Compounds of aluminium
    • C01F7/02Aluminium oxide; Aluminium hydroxide; Aluminates
    • C01F7/34Preparation of aluminium hydroxide by precipitation from solutions containing aluminium salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Geology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Luminescent Compositions (AREA)
  • Chemical Treatment Of Metals (AREA)

Abstract

The present invention provides a process for the preparation of an antacid material based upon magnesium aluminium hydroxide, wherein magnesium hydroxide and/or magnesium oxide is reacted in an atomic ratio of magnesium to aluminium of 1:1 to 3:1 with an aqueous solution of aluminium sulphate until the pH of the reaction mixture is from 4.0 to 8.0, whereafter water-soluble components are removed from the mixture in known manner and this is isolated and, if desired, dried. The present invention also provides pharmaceutical compositions containing an antacid material prepared by this process, in admixture with a conventional pharmaceutical adjuvant. Furthermore, the present invention provides a method of combating hyperacidity and gastrointestinal diseases, which comprises administering an antacid material prepared by the above process.
FI811542A 1980-05-19 1981-05-19 Process for the preparation of an acid neutralizing agent based on magnesium aluminum hydrox FI72652C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3019032 1980-05-19
DE3019032A DE3019032C2 (en) 1980-05-19 1980-05-19 Magnesium aluminum hydroxide based antacid active ingredient, its manufacture and use

Publications (3)

Publication Number Publication Date
FI811542L true FI811542L (en) 1981-11-20
FI72652B FI72652B (en) 1987-03-31
FI72652C FI72652C (en) 1987-07-10

Family

ID=6102747

Family Applications (1)

Application Number Title Priority Date Filing Date
FI811542A FI72652C (en) 1980-05-19 1981-05-19 Process for the preparation of an acid neutralizing agent based on magnesium aluminum hydrox

Country Status (16)

Country Link
US (1) US4482542A (en)
EP (1) EP0040521B1 (en)
JP (2) JPS5711919A (en)
AT (1) ATE4169T1 (en)
AU (1) AU541114B2 (en)
DD (1) DD158506A5 (en)
DE (2) DE3019032C2 (en)
DK (1) DK156197C (en)
ES (1) ES502318A0 (en)
FI (1) FI72652C (en)
GR (1) GR75632B (en)
HU (1) HU184854B (en)
PH (2) PH16895A (en)
SU (1) SU1056876A3 (en)
YU (1) YU43495B (en)
ZA (1) ZA812986B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904457A (en) * 1974-03-30 1990-02-27 Aluminum Company Of America Synthetic hydrotalcite
USRE34164E (en) * 1974-03-30 1993-01-19 Aluminum Company Of America Synthetic hydrotalcite
DE3408463C2 (en) * 1984-03-08 1987-02-26 Giulini Chemie Gmbh, 6700 Ludwigshafen Process for the preparation of an aluminum and magnesium-containing compound of the formula Al↓5↓Mg↓1↓↓0↓(OH)↓3↓↓1↓(SO↓4↓)↓2↓ . x H↓2↓O
US4869902A (en) * 1984-04-19 1989-09-26 Rorer Pharmaceutical Corporation Antacid composition
DE3429263A1 (en) * 1984-08-08 1986-02-20 Gödecke AG, 1000 Berlin Process for the stabilisation of filterable antacids with hexitols
US4656156A (en) * 1986-01-21 1987-04-07 Aluminum Company Of America Adsorbent and substrate products and method of producing same
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
GB2514840A (en) 2013-06-07 2014-12-10 Imerys Minerals Ltd Compositions for bleaching pulps and their use
WO2015004663A1 (en) 2013-07-08 2015-01-15 Phinergy Ltd. Electrolyte regeneration
CN106663830B (en) 2014-04-13 2019-07-05 奥科宁克有限公司 For the regenerated system and method for aqueous alkali
WO2018229789A1 (en) 2017-06-12 2018-12-20 Council Of Scientific & Industrial Research An inorganic base antacid compound with improved and novel properties

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB933405A (en) * 1960-07-01 1963-08-08 Keystone Chemurgic Corp Hydrated magnesium aluminate
US3239416A (en) * 1963-05-29 1966-03-08 Armour Pharma Aluminum hydroxide-metal hydroxide antacid and process of making the same
JPS5120997B2 (en) * 1971-12-25 1976-06-29
GB1363399A (en) * 1972-04-13 1974-08-14 Rotta Research Lab Method of preparing an antacid pharmaceutical product
US4105579A (en) * 1976-03-04 1978-08-08 Barcroft Company Process for producing pharmaceutical grade aluminum hydroxide gels

Also Published As

Publication number Publication date
DD158506A5 (en) 1983-01-19
AU541114B2 (en) 1984-12-13
EP0040521A1 (en) 1981-11-25
ES8203608A1 (en) 1982-04-01
EP0040521B1 (en) 1983-07-20
DK156197C (en) 1989-11-27
DK218281A (en) 1981-11-20
FI72652C (en) 1987-07-10
DE3019032C2 (en) 1983-09-01
YU125881A (en) 1983-10-31
HU184854B (en) 1984-10-29
SU1056876A3 (en) 1983-11-23
DE3019032A1 (en) 1981-11-26
YU43495B (en) 1989-08-31
DE3160645D1 (en) 1983-08-25
ES502318A0 (en) 1982-04-01
FI72652B (en) 1987-03-31
JPS5711919A (en) 1982-01-21
PH17413A (en) 1984-08-08
AU7082181A (en) 1981-11-26
US4482542A (en) 1984-11-13
ZA812986B (en) 1982-04-28
ATE4169T1 (en) 1983-08-15
JPH0341029A (en) 1991-02-21
DK156197B (en) 1989-07-10
PH16895A (en) 1984-04-02
JPH0352409B2 (en) 1991-08-09
GR75632B (en) 1984-08-01

Similar Documents

Publication Publication Date Title
FI811542L (en) PAO MAGNESIUM ALUMINUM HYDROXIDE BASERAT SYRA NEUTRALISERANDE AEMNE OCH DESS FRAMSTAELLNING
KR840000528A (en) Method for preparing bis-triazole derivative
PT77616B (en) Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same
DE3165790D1 (en) STABILIZED TETRAZOLIUM SALT PREPARATION
Gilman et al. Relative Reactivities of Organometallic Compounds of the Alkaline Earth Group1
DE3378580D1 (en) Imidazolylphenyl-tetrahydropyridazines, process for their preparation and pharmaceutical compositions containing them
IL70160A (en) 6alpha-methylcorticoids,processes for their preparation and pharmaceutical compositions containing them
AU584235B2 (en) New tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing them
DE3062542D1 (en) Process for the preparation of erythro-alpha-2-piperidyl-2,8-bis (trifluoromethyl)-4-quinoline methanol
DE3378413D1 (en) Spiro-2-aza-alkane-3-carbonitriles, process for their preparation and their use
IL60323A0 (en) Pseudotrisaccharide compounds,their preparation and their medicinal use
JPS5527824A (en) Production of alumina sol
SE7805273L (en) SALT
KR850008619A (en) Process for preparing nifedipine composition
Ferraro et al. Reaction of Some Metallic Oxides with Liquid Dinitrogen Tetroxide. Oxides of the First and Second Periodic Groups and Lead1
JPS5212129A (en) Process for preparation of fluorocarbonvinylether
JPS5214721A (en) Process for preparation of sodium malate hydrate
JPS51138644A (en) Process for preparation of pure styrene sulfonic acid metal salt
SU919986A1 (en) Method of producing dehydrated mercury difluoride
JPS53137895A (en) Preparation of basic aluminium salt
ES8101579A1 (en) Americanin
JPS56161377A (en) Preparation of 1,4-bis 3-hydroxypropyl hexahydro-1h-1,4- diazepine
JPS5692229A (en) Preparation of 5-hexynyl alcohol
JPS54148773A (en) Preparation of phthalide
JPS5659712A (en) Macrophage inhibitor and its preparation

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: GOEDECKE AKTIENGESELLSCHAFT